期刊文献+

2种定量PCR法与探针杂交法在检测重组白介素1受体拮抗剂中宿主DNA残留量的比较 被引量:2

Comparative study of two quantitative PCR methods and the probe hybridization method on residual host genomic DNA assay of recombinant human interleukin 1 receptor antagonist
原文传递
导出
摘要 目的:建立Taqman探针技术的定量PCR方法,对大肠杆菌E.coli/BL21菌株生产的重组白介素1受体拮抗剂(rhIL^-1ra)中的残留宿主DNA进行了定量分析,并与SYBR Green法和地高辛探针杂交法进行比较。方法:以BioRad Chromo 4荧光定量PCR仪为平台,选择大肠杆菌23S核糖体RNA基因为靶基因,设计引物和Taqman探针,以纯化的宿主基因组DNA为标准品,对供试品中残留DNA进行定量。同时在重复性,精密度,检测限等方面与SYBR Green方法和地高辛探针杂交法进行比较。结果:本实验建立的Taqman探针法检测限为0.01 ng·mL^-1,在0.01~1000 ng·mL^-1区间同样具有良好的线性(r=0.997),回收率89.7%~136.0%。测定4批次供试品中残留DNA浓度为0.052、0.092、0.096、0.025 ng·mL^-1。结论:Taqman探针法与SYBR Green法检测灵敏度均达到0.01 ng·mL^-1,在重复性与精密度方面效果一致,且均优于探针杂交方法。 Objective: To develop a Taqman probe-based quantitative PCR method for the determination of residual host genomic DNA in E.coli/BL21 recombinant human interleukin-1 antagonist(rhIL^-1Ra),and to compare the efficiency of the method with that of SYBR Green PCR method and digoxin (DIG) probe hybridization method. Methods: Based on BioRad Chromo 4 system,PCR primer and Taqman probe were designed to amplify 23S ribosomal RNA of E.coli.Residual host DNA concentration was calculated by simple linear regression with standard host genomic DNA sample.Repeatability,efficiency and limit of detection of this method were compared with that of SYBR Green method and DIG probe hybridization method. Results: The limit of detection of the Taqman probe PCR method for E.coli genomic was 0.01 ng · mL^-1,and this method showed a good linearity within the test range of 0.01-1000 ng·mL^-1(r=0.997) and the recovery was between 89.7%-132%.The residual DNA concentrations of 4 tested product batches were 0.052,0.092,0.096,0.025 ng· mL^-1 respectively. Conclusion: The Taqman method and the SYBR Green method both have high sensitivity of 0.01 ng·mL^-1 and high repeatability and accuracy,and significantly outperform the probe hybridization method.
出处 《药物分析杂志》 CAS CSCD 北大核心 2014年第1期140-145,共6页 Chinese Journal of Pharmaceutical Analysis
关键词 大肠杆菌 定量PCR 宿主残留DNA 重组白介素1受体拮抗剂 质量控制 Taqmen探针 E. coli quantitative PCR host residual DNA recombinant IL - 1Ra quality control Taqmen probe
  • 相关文献

参考文献4

二级参考文献22

  • 1张瑞福,崔中利,李顺鹏.土壤微生物群落结构研究方法进展[J].土壤,2004,36(5):476-480. 被引量:39
  • 2饶春明,赵阳,李永红,王军志.应用荧光法测定重组细胞因子中残余DNA含量[J].药物分析杂志,2005,25(12):1417-1419. 被引量:22
  • 3李亮助,刘勇,王贻杰,程海,孙茂盛,邵一鸣.Real-time PCR检测核酸疫苗中宿主基因组残留DNA[J].中国生物制品学杂志,2007,20(6):439-441. 被引量:8
  • 4EU. Position statement on the use of tumorigenic cells of human origin for the production of biological and bioteehnological medicinal products. The European Agency for the Evaluation of Medieinal Products : Evaluation of medicinal products for human use. CPMP/BWP/1143/ 00 2001.
  • 5FDA. Points to consider in the manufacture and testing of monoclonal antibody products for human use. US Department of Health and Human Services,Food and Drug Administration, Center for Biologics Evaluation and Research 1997.
  • 6WANG Jun-zhi(王军志).Research & Development and Quality Control of Biotechnical Drugs(2nd Ed)(生物技术药物研究开发和质量控制)(第二版).Beijing(北京):Science Press(科学出版社),2007.98.
  • 7Singer VL, Jones LJ, Yue ST, et al. Characterization of PicoGreen reagent and development of a fluorescence - based solution assay for double - stranded DNA quantitation. Anal Biochem, 1997,249 ( 2 ) : 228.
  • 8Wolter TRA. Assays for controlling host - cell impurities in biopharmaceutieals. BioProcess Int, 2005,3 (2) :40.
  • 9Nissom PM. Specific detection of residual CHO host cell DNA by real - time PCR. Biologicals ,2007,35 ( 3 ) :211.
  • 10Morrison TB, Weis JJ, Wittwer CT. Quantification of low - copy transcripts by continuous SYBR Green Ⅰ monitoring during amplification. Biotechniques, 1998,24 ( 6 ) : 954.

共引文献48

同被引文献19

  • 1Petricciani J, Knezevic I. Animal cell substrates for the production of biologicals: An introduction to WHO documents. Biologicals, 2014, pii:SI045-S1056.
  • 2World Health Organization. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks. Replacement of annex 1, TRS, 878. technical report series 978, annex 3. http://www.who.int/biologicals/vaccincs/TRS 978 Annex_3.ixlt?ual.
  • 3Knezevic I1, Stacey G Petricciani J, et al. WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007. Biologicals, 2008, 36(3):203-211.
  • 4Knezevic I, Stacey Petricciani J, et al. Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substratcs for the Production of Biologicals, 22-23 April 2009, Bethesda, USA. Biologicals, 2010, 38(1):162-169.
  • 5Hussain M. A direct qPCR method for residual DNA quantification in monoclonal untibody drugs produced in CHO cells. J Pharm Biomed Anal, 2015, 115:603-606.
  • 6Peper G Fankhauser A, Merlin I", et al. Direct real-time quantitative PCR for measurement of host-cell residual DNA in therapeutic proteins. J Pharm Biomed Anal, 2014, I00:123-130.
  • 7Peden K, Sheng L, Pal A, et al. Biological activity of residual cell-substrate DNA. Dev Biol (Basel), 2006, 123:45=53; discussion 55-73.
  • 8Sheng-Fowler L, Cai F, Fu H, et al. Tumors induced in mice by direct inoculation of plasmid DNA expressing both activated H-ras and c=myc. Int J Biol Sci, 2010, 6(2):151-162.
  • 9Yang H. Establishing acceptable limits of residual DNA. PDA J Phann Sci Technol, 2013, 67(2):155-163.
  • 10王兰,高凯,毕华,李永红,饶春明.荧光法和DNA杂交法检测重组技术产品中残余DNA的比较[J].药物分析杂志,2009,29(7):1063-1066. 被引量:31

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部